Home Cart Sign in  
Chemical Structure| 1187990-87-9 Chemical Structure| 1187990-87-9

Structure of MK-8617
CAS No.: 1187990-87-9

Chemical Structure| 1187990-87-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

MK-8617 is a potent, selective, orally bioavailabl pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1−3 (HIF PHD1−3), inhibiting PHD1, 2, 3 with IC50s of 1.0, 1.0 and 14 nM, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MK-8617

CAS No. :1187990-87-9
Formula : C24H21N5O4
M.W : 443.45
SMILES Code : O=C(C1=CN=C(C2=NN=CC=C2)NC1=O)NC(C3=CC=C(OC)C=C3)C4=CC=C(OC)C=C4
MDL No. :MFCD22572348
InChI Key :WXLPERVDMILVIF-UHFFFAOYSA-N
Pubchem ID :44230662

Safety of MK-8617

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of MK-8617

epigenetics

Isoform Comparison

Biological Activity

Target
  • PHD2

    PHD2, IC50:1 nM

  • PHD3

    PHD3, IC50:14 nM

  • PHD1

    PHD1, IC50:1 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Purified human primary NK cells 10 μM 18 hours MK-8617 did not directly promote NK cell IFN-γ production in the presence of IL-12 PMC8693168
Peripheral blood mononuclear cells 10 μM 18 hours Screening for active compounds enhancing IFN-γ production by NK cells, MK-8617 increased the IFN-γ+ ratio in NK cells in the presence of IL-12 PMC8693168

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Polytrauma and hemorrhagic shock model Oral or intravenous 0.5 mg or 1 mg Single dose MK-8617 reduced lactate elevation in the trauma and hemorrhagic shock model and significantly improved 60-minute survival in the lethal hemorrhagic shock model. PMC10873291

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.26mL

0.45mL

0.23mL

11.28mL

2.26mL

1.13mL

22.55mL

4.51mL

2.26mL

References

 

Historical Records

Categories